US reproductive laws could limit women’s participation in clinical trials
It has been over two years since the US Supreme Court’s decision in Dobbs versus Jackson Women’s Health to overturn…
All articles by Phalguni Deswal
Phalguni Deswal
@Phalguni_GD
Phalguni Deswal is reporter in the healthcare and pharmaceutical sector. With a background in medicine, Phalguni has experience working in the Indian healthcare sector. Phalguni is interested in metabolic drug therapies, digital health technologies, and drug development.
-
-
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Eli Lilly has scored a win in the ongoing competition with Novo Nordisk in the obesity space, as a Phase…
-
VivaVision to advance non-steroidal therapy in Phase III following Phase II win
China-headquartered VivaVision Biotech is looking to advance its non-steroidal therapy, VVN461-CS-201 (VVN461), in a Phase III trial after the candidate…
-
Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application…
-
Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial
Outlook Therapeutics’ second attempt to obtain US approval for its wet age-related macular degeneration (wet AMD) therapy, Lytenava (bevacizumab-vikg) has…
-
Alector stock drops after Alzheimer’s drug fails in Phase II trial
Alector’s internal pipeline suffered a blow as the Phase II INVOKE-2 trial evaluating its Alzheimer’s disease therapy, AL002, failed to…
-
Orbus’s combo misses primary endpoint in Phase III brain cancer trial
Orbus Therapeutics’ lead therapy eflornithine has failed to achieve the primary endpoint in the Phase III STELLAR trial, evaluating it…
-
Daiichi Sankyo exec on purposeful data collection
Daiichi Sankyo’s VP of digital excellence, Dr Patrick Markt-Niederreiter , has outlined how the pharma company makes ‘very conscious’ decisions…
-
Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
Pharmaceutical companies are always looking to increase the efficiency of clinical trials, and now many of these companies are looking…
-
Intelligent gears up for FDA approval of fingerprint drug detection device
US based company Intelligent Bio Solutions has released “strong initial results” from a pharmacokinetic (PK) study and is one step…